Literature DB >> 11606831

Influence of cell-free Hb on local tissue perfusion and oxygenation in acute anemia after isovolemic hemodilution.

A G Tsai1.   

Abstract

BACKGROUND: Oxygen-carrying solutions are intended to eliminate the blood transfusion trigger. Their ability to maintain microvascular perfusion and to deliver oxygen to tissue when they replace the RBCs as oxygen carriers has not been directly measured. STUDY DESIGN AND METHODS: Microvascular response to exchange transfusion with a polymerized bovine cell-free Hb (PBH) solution after acute isovolemic hemodilution with a plasma expander was investigated by using the hamster window model. In vivo functional capillary density (FCD), blood flow, and high-resolution oxygen distribution in microvascular networks were measured by noninvasive methods.
RESULTS: Exchange transfusion of PBH solution after a 60-percent isovolemic hemodilution with dextran 70 (MW, 70 kDa) resulted in a Hct of 11 percent and a Hb content of 6.7 g per dL. FCD was 0.37 of baseline. Interstitial pO2 was reduced from 21.0 mm Hg to 0.3 mmHg. Arteriolar and venular blood flows were ratios of 0.75 and 0.76 relative to baseline. In a previous study, tissue pO2 after hemodilution to 5.6 g of Hb per dL with dextran 70 was 23.0 mmHg. Hypervolemic injection of PBH solution increased blood pressure and caused vasoconstriction.
CONCLUSION: Using PBH solution to replace RBC oxygen-carrying capacity during low Hb content conditions (<50%) causes abnormally low tissue oxygenation and FCD, while the same level of hemodilution with dextran maintains normal microvascular conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606831     DOI: 10.1046/j.1537-2995.2001.41101290.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers.

Authors:  Amy G Tsai; Pedro Cabrales; Belur N Manjula; Seetharama A Acharya; Robert M Winslow; Marcos Intaglietta
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

2.  Vital organ tissue oxygenation after serial normovolemic exchange transfusion with HBOC-201 in anesthetized swine.

Authors:  William W Muir; Govindasamy Ilangovan; Jay L Zweier; Paula F Moon-Massat; Virginia T Rentko
Journal:  Shock       Date:  2011-06       Impact factor: 3.454

3.  Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

Authors:  M Zouhair Atassi; Catherine Childress
Journal:  Protein J       Date:  2005-01       Impact factor: 2.371

4.  Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin.

Authors:  Kim D Vandegriff; Andrea Bellelli; Michele Samaja; Ashok Malavalli; Maurizio Brunori; Robert M Winslow
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

5.  Oxygen delivery during extreme anemia with ultra-pure earthworm hemoglobin.

Authors:  Jacob Elmer; Andre F Palmer; Pedro Cabrales
Journal:  Life Sci       Date:  2012-09-13       Impact factor: 5.037

6.  A computational model of oxygen delivery by hemoglobin-based oxygen carriers in three-dimensional microvascular networks.

Authors:  Nikolaos M Tsoukias; Daniel Goldman; Arjun Vadapalli; Roland N Pittman; Aleksander S Popel
Journal:  J Theor Biol       Date:  2007-06-16       Impact factor: 2.691

7.  Non-hypertensive tetraPEGylated canine haemoglobin: correlation between PEGylation, O2 affinity and tissue oxygenation.

Authors:  Seetharama A Acharya; Vivek N Acharya; Nirmala Devi Kanika; Amy G Tsai; Marcos Intaglietta; Belur N Manjula
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

8.  Effects of non-leukocyte-reduced and leukocyte-reduced packed red blood cell transfusions on oxygenation of rat spinotrapezius muscle.

Authors:  Sripriya Sundararajan; Sami C Dodhy; Roland N Pittman; Stephen J Lewis
Journal:  Microvasc Res       Date:  2013-11-02       Impact factor: 3.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.